Your browser doesn't support javascript.
loading
Dynamics of human milk oligosaccharides in early lactation and relation with growth and appetitive traits of Filipino breastfed infants.
Samuel, Tinu M; Hartweg, Mickaël; Lebumfacil, Jowena D; Buluran, Katherine B; Lawenko, Rachel B; Estorninos, Elvira M; Binia, Aristea; Sprenger, Norbert.
Affiliation
  • Samuel TM; Nestlé Product Technology Center-Nutrition, Société des Produits Nestlé S.A., 1800, Vevey, Switzerland.
  • Hartweg M; Clinical Research Unit, Société des Produits Nestlé SA, 1000, Lausanne, Switzerland.
  • Lebumfacil JD; Clinical Research Operations, Wyeth Philippines, Inc., Makati City, 1200, Philippines.
  • Buluran KB; Asian Hospital & Medical Center, Muntinlupa City, 1780, Philippines.
  • Lawenko RB; Asian Hospital & Medical Center, Muntinlupa City, 1780, Philippines.
  • Estorninos EM; Asian Hospital & Medical Center, Muntinlupa City, 1780, Philippines.
  • Binia A; Nestlé Institute of Health Sciences, Société des Produits Nestlé SA, 1000, Lausanne, Switzerland.
  • Sprenger N; Nestlé Institute of Health Sciences, Société des Produits Nestlé SA, 1000, Lausanne, Switzerland. norbert.sprenger@rdls.nestle.com.
Sci Rep ; 12(1): 17304, 2022 10 15.
Article in En | MEDLINE | ID: mdl-36243744
ABSTRACT
Human milk oligosaccharides play a key role in the maturation of the infant gut microbiome and immune system and are hypothesized to affect growth. This study examined the temporal changes of 24 HMOs and their associations to infant growth and appetitive traits in an exploratory, prospective, observational, study of 41 Filipino mother-infant dyads. Exclusively breastfed, healthy, term infants were enrolled at 21-26 days of age (≈ 0.75 mo) and followed for 6 months. Infant growth measures and appetitive traits were collected at visit 1 (V1) (≈ 0.75 mo), V2 (≈ 1.5 mo), V3 (2.5 mo), V4 (2.75 mo), V5 (4 mo), and V6 (6 mo), while HMOs were measured at V1, V2, V3 and V5. Overall exposure to each HMO was summarized as area under the curve from baseline to 4 months of age and examined in association with each measure of growth at 6 months using linear regression adjusted for maternal age at birth, infant sex, birth weight, and mode of delivery. We saw modest associations between several HMOs and infant growth parameters. Our results suggest that specific HMOs, partly as proxy for milk groups (defined by Secretor and Lewis status), may be associated with head circumference and length, increasing their relevance especially in populations at the lower end of the WHO growth curve. We did not identify the same HMOs associated with infant appetitive traits, indicating that at least in our cohort, changes in appetite were not driving the observed associations between HMOs and growth.Clinical trial registration NCT03387124.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Feeding / Milk, Human Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Infant / Newborn Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Feeding / Milk, Human Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Infant / Newborn Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Suiza